Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

949596979899100101102

WINNERS & LOSERS SUMMARY: ConvaTec Slumps On "Disappointing" Results

14th Feb 2019 11:17

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Micro up Read More

LONDON MARKET OPEN: Micro Focus, AstraZeneca Keep FTSE In Rally Mode

14th Feb 2019 08:36

LONDON (Alliance News) - The FTSE 100 was sustaining its recent winning streak in early trade on Thursday, boosted by well-received annual results from Micro Focus International a Read More

LONDON MARKET PRE-OPEN: Lower Call; Restaurant Group CEO To Depart

14th Feb 2019 07:46

LONDON (Alliance News) - London share prices are set to pull back slightly on Thursday following three consecutive sessions of gains which had been driven by hopes of a trade detente between the a Read More

TOP NEWS: AstraZeneca Profit Falls, Guides To Earnings Growth In 2019

14th Feb 2019 07:46

LONDON (Alliance News) - AstraZeneca PLC on Thursday posted a drop in annual profit after getting a boost from its Lynparza cancer drug collaboration the year before, though guided to earnings for Read More

UK Earnings, Trading Statements Calendar - Next 7 Days

7th Feb 2019 16:07

Friday 8 February SSETrading Statement ShaftesburyTrading 11 MiningFull 12 Read More

TOP NEWS: AstraZeneca's Fasenra Gets US FDA Orphan Drug Designation

6th Feb 2019 07:57

LONDON (Alliance News) - AstraZeneca PLC on Wednesday said the US Food & Drug Administration has granted Orphan Drug Designation to Fasenra for the treatment of hypereosinophilic is first drug Read More

LONDON MARKET PRE-OPEN: Barratt Profit Up; Interserve Gets Debt Deal

6th Feb 2019 07:46

LONDON (Alliance News) - Stock prices in London on Wednesday are set to pull back from Tuesday's rally, while the pound remained below the USD1.30 mark after disappointing UK data released in Read More

BROKER RATINGS SUMMARY: Citigroup And Goldman Downgrade Property Firms

25th Jan 2019 09:47

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and late Thursday:----------FTSE 100----------GOLDMAN RAISES TO - TO Read More

Circassia Pharma To Acquire Full US Tudorza Rights From AstraZeneca

11th Dec 2018 13:15

LONDON (Alliance News) - Circassia Pharmaceuticals PLC said Tuesday it plans to exercise its option to acquire the full US rights to the Tudorza chronic obstructive pulmonary disease drug from to Read More

Dr Reddy's Launches Over-The-Counter Version Of AstraZeneca's Prilosec

11th Dec 2018 06:50

NEW DELHI (Alliance News) - Dr. Reddy's Laboratories Ltd announced the launch of Omeprazole Delayed-Release Tablets, 20 mg, an over-the-counter store-brand equivalent of Prilosec OTC Tablets, Read More

TOP NEWS: Imfinzi Fails To Meet Primary Endpoint In AstraZeneca Trial

7th Dec 2018 08:36

LONDON (Alliance News) - Pharmaceticals form AstraZeneca PLC on Friday said its phase three Eagle trial of Imfinzi in advanced head and neck cancer patients failed to meet its primary study alone, Read More

European Markets Tumble On Weak Oil Prices And Trade Worries

6th Dec 2018 17:32

BRUSSELS/FRANKFURT/PARIS (Alliance News) - The European markets ended Thursday's session sharply lower, extending the losses from the previous two days. Falling crude oil prices and the Read More

Majedie Investments Net Assets Fall As It Hikes Payout, Redeems Debt

5th Dec 2018 11:56

LONDON (Alliance News) - Majedie Investments PLC on Wednesday reported a decrease in net asset value over its financial year due to making higher dividend payouts and redeeming debentures, as its Read More

AstraZeneca's Long-Term Calquence Leukaemia Study Results Encouraging

4th Dec 2018 18:27

LONDON (Alliance News) - AstraZeneca PLC on Monday presented long-term follow-up data from a trial of Calquence in chronic lymphocytic leukaemia patients which showed a sustained a meaningful to a Read More

TOP NEWS: AstraZeneca Sells Nexium And Vimovo Rights To Grunenthal

3rd Dec 2018 08:12

LONDON (Alliance News) - AstraZeneca PLC said Monday it has completed an agreement to divest the prescription medicine rights to Nexium in Europe and the global rights, excluding the US and Japan, Read More

AstraZeneca To Work With Belgian Diagnostics Firm On Lung Cancer Test

29th Nov 2018 10:12

LONDON (Alliance News) - Belgium-based diagnostics firm Biocartis Group NV on Thursday unveiled an agreement with AstraZeneca PLC in which the two will work to improve the speed of lung cancer be Read More

TOP NEWS: AstraZeneca Gets Orphan Drug Designation For Fasenra

26th Nov 2018 08:21

LONDON (Alliance News) - AstraZeneca PLC said Monday the US Food & Drug Administration has granted orphan drug designation to Fasenra for the treatment of eosinophilic granulomatosis with a to Read More

Redx Pharma Posts Large Annual Loss, Appoints Astra Executive As CFO

19th Nov 2018 13:07

LONDON (Alliance News) - Redx Pharma PLC on Monday posted a large loss due to the absence of a big exceptional disposal gain seen a year before and said that it has appointed James Mead as its new Read More

Consort Appoints Former AstraZeneca Executive As Chairman Designate

6th Nov 2018 09:16

LONDON (Alliance News) - Drug delivery devices manufacturer Consort Medical PLC said Tuesday it has appointed Chris Brinsmead as non-executive director and chairman designate of the will join the Read More

TOP NEWS: AstraZeneca Sells Medicine Rights For USD350 Million

6th Nov 2018 08:14

LONDON (Alliance News) - Pharmaceutical firm AstraZeneca PLC said on Tuesday it has agreed to sell its rights to the medicines Alvesco, Omnaris and Zetonna to Switzerland-based Covis Pharma BV for Read More

949596979899100101102
FTSE 100 Latest
Value10,600.53
Change-2.95